J Patrik Fägerstam1, Per A Whiss. 1. Division of Radiology, Department of Medicine and Care, Faculty of Health Sciences, Linköping University, Sweden.
Abstract
AIM: To observe if the total amount of platelet P-selectin (tP-selectin) in patients with inflammatory bowel disease (IBD) was related to disease entity or activity, 5-aminosalicylic acid (5-ASA) medication or gender. METHODS: tP-selectin was measured by immunoassay in seventeen IBD patients and twelve healthy controls. RESULTS: Compared to controls, there was no difference of tP-selectin in patients related to disease entity or activity and 5-ASA medication. When the groups were split according to gender the male patient group showed higher levels of tP-selectin compared to male controls (153 ng/mL vs 94 ng/mL, P<0.05). CONCLUSION: Increased tP-selectin levels may alter the inflammatory response and susceptibility to thromboembolic disease. As previously shown with soluble P-selectin, tP-selectin shows gender dependent differences important to consider in future studies.
AIM: To observe if the total amount of platelet P-selectin (tP-selectin) in patients with inflammatory bowel disease (IBD) was related to disease entity or activity, 5-aminosalicylic acid (5-ASA) medication or gender. METHODS: tP-selectin was measured by immunoassay in seventeen IBDpatients and twelve healthy controls. RESULTS: Compared to controls, there was no difference of tP-selectin in patients related to disease entity or activity and 5-ASA medication. When the groups were split according to gender the male patient group showed higher levels of tP-selectin compared to male controls (153 ng/mL vs 94 ng/mL, P<0.05). CONCLUSION: Increased tP-selectin levels may alter the inflammatory response and susceptibility to thromboembolic disease. As previously shown with soluble P-selectin, tP-selectin shows gender dependent differences important to consider in future studies.
Authors: B Jilma; J Hildebrandt; S Kapiotis; O F Wagner; E Kitzweger; C Müllner; B Monitzer; K Krejcy; H G Eichler Journal: J Clin Endocrinol Metab Date: 1996-06 Impact factor: 5.958
Authors: Sunil K Nadar; Andrew D Blann; Sridhar Kamath; D Gareth Beevers; Gregory Y H Lip Journal: J Am Coll Cardiol Date: 2004-07-21 Impact factor: 24.094
Authors: P L Beck; E Ihara; S A Hirota; J A MacDonald; D Meng; N N Nanthakumar; D K Podolsky; R J Xavier Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-03-18 Impact factor: 4.052
Authors: Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander Journal: World J Gastroenterol Date: 2011-02-07 Impact factor: 5.742